Susquehanna International Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$78.6M Buy
2,849,112
+1,620,401
+132% +$44.7M 0.01% 135
2025
Q1
$34.8M Sell
1,228,711
-894,997
-42% -$25.4M 0.01% 210
2024
Q4
$88.3M Buy
2,123,708
+815,129
+62% +$33.9M 0.01% 117
2024
Q3
$87.5M Buy
1,308,579
+1,089,765
+498% +$72.8M 0.02% 89
2024
Q2
$26M Buy
218,814
+4,183
+2% +$497K ﹤0.01% 306
2024
Q1
$22.9M Sell
214,631
-224,975
-51% -$24M ﹤0.01% 323
2023
Q4
$43.7M Buy
439,606
+107,579
+32% +$10.7M 0.01% 195
2023
Q3
$34.3M Sell
332,027
-202,372
-38% -$20.9M 0.01% 265
2023
Q2
$64.9M Buy
534,399
+253,789
+90% +$30.8M 0.01% 142
2023
Q1
$43.1M Sell
280,610
-31,802
-10% -$4.88M 0.01% 224
2022
Q4
$56.1M Sell
312,412
-404,328
-56% -$72.6M 0.01% 138
2022
Q3
$84.8M Buy
716,740
+343,125
+92% +$40.6M 0.02% 72
2022
Q2
$53.4M Sell
373,615
-114,180
-23% -$16.3M 0.01% 129
2022
Q1
$84M Buy
487,795
+354,840
+267% +$61.1M 0.01% 124
2021
Q4
$33.8M Sell
132,955
-568,255
-81% -$144M 0.01% 299
2021
Q3
$270M Buy
701,210
+547,724
+357% +$211M 0.04% 43
2021
Q2
$36.1M Sell
153,486
-845,048
-85% -$199M 0.01% 336
2021
Q1
$131M Buy
998,534
+296,592
+42% +$38.8M 0.02% 100
2020
Q4
$73.3M Buy
701,942
+133,878
+24% +$14M 0.01% 146
2020
Q3
$40.2M Sell
568,064
-41,916
-7% -$2.97M 0.01% 186
2020
Q2
$39.2M Buy
609,980
+268,354
+79% +$17.2M 0.01% 190
2020
Q1
$10.2M Buy
341,626
+216,857
+174% +$6.5M ﹤0.01% 403
2019
Q4
$2.44M Buy
+124,769
New +$2.44M ﹤0.01% 1243
2019
Q3
Sell
-89,985
Closed -$1.32M 4810
2019
Q2
$1.32M Buy
+89,985
New +$1.32M ﹤0.01% 1726
2019
Q1
Sell
-25,494
Closed -$389K 3972
2018
Q4
$389K Buy
+25,494
New +$389K ﹤0.01% 2355